| Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational … N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ... The lancet Diabetes & endocrinology 8 (4), 301-312, 2020 | 187 | 2020 |
| Utility of plasma concentration of trimethylamine N-oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes SA Winther, JC Øllgaard, N Tofte, L Tarnow, Z Wang, TS Ahluwalia, ... Diabetes care 42 (8), 1512-1520, 2019 | 97 | 2019 |
| Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes N Tofte, T Suvitaival, L Ahonen, SA Winther, S Theilade, M Frimodt-Møller, ... Scientific reports 9 (1), 16398, 2019 | 69 | 2019 |
| Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes S Pilemann-Lyberg, TW Hansen, N Tofte, SA Winther, S Theilade, ... Diabetes Care 42 (6), 1088-1094, 2019 | 66 | 2019 |
| Metabolomic assessment reveals alteration in polyols and branched chain amino acids associated with present and future renal impairment in a discovery cohort of 637 persons … N Tofte, T Suvitaival, K Trost, IM Mattila, S Theilade, SA Winther, ... Frontiers in endocrinology 10, 818, 2019 | 46 | 2019 |
| Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients N Tofte, C Jensen, M Tvede, CB Andersen, J Carlsen, M Iversen Scandinavian journal of infectious diseases 44 (11), 835-841, 2012 | 40 | 2012 |
| Soluble urokinase plasminogen activator receptor predicts cardiovascular events, kidney function decline, and mortality in patients with type 1 diabetes V Rotbain Curovic, S Theilade, SA Winther, N Tofte, J Eugen-Olsen, ... Diabetes care 42 (6), 1112-1119, 2019 | 35 | 2019 |
| Markers of collagen formation and degradation reflect renal function and predict adverse outcomes in patients with type 1 diabetes S Pilemann-Lyberg, DGK Rasmussen, TW Hansen, N Tofte, SA Winther, ... Diabetes Care 42 (9), 1760-1768, 2019 | 34 | 2019 |
| Characteristics of high‐and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in … N Tofte, M Lindhardt, K Adamova, J Beige, JWJ Beulens, AL Birkenfeld, ... Diabetic Medicine 35 (10), 1375-1382, 2018 | 28 | 2018 |
| Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus NH Tougaard, S Theilade, SA Winther, N Tofte, TS Ahluwalia, TW Hansen, ... Journal of the American Heart Association 9 (19), e017165, 2020 | 27 | 2020 |
| Plasma metabolomics identifies markers of impaired renal function: a meta-analysis of 3089 persons with type 2 diabetes N Tofte, N Vogelzangs, D Mook-Kanamori, A Brahimaj, J Nano, ... The Journal of Clinical Endocrinology & Metabolism 105 (7), 2275-2287, 2020 | 27 | 2020 |
| Chronic urinary tract infections in patients with spinal cord lesions–biofilm infection with need for long‐term antibiotic treatment N Tofte, ACY Nielsen, H Trøstrup, CB Andersen, M Von Linstow, ... Apmis 125 (4), 385-391, 2017 | 20 | 2017 |
| Omics research in diabetic kidney disease: new biomarker dimensions and new understandings? N Tofte, F Persson, P Rossing Journal of nephrology 33, 931-948, 2020 | 14 | 2020 |
| PRIORITY investigators. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a … N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ... Lancet Diabetes Endocrinol 8 (4), 301-312, 2020 | 13 | 2020 |
| Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes V Rotbain Curovic, S Theilade, SA Winther, N Tofte, L Tarnow, A Jorsal, ... Diabetic Medicine 38 (5), e14459, 2021 | 12 | 2021 |
| Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes LF Ferreira-Divino, T Suvitaival, V Rotbain Curovic, N Tofte, K Trošt, ... Cardiovascular Diabetology 21 (1), 135, 2022 | 11 | 2022 |
| Changes in diabetes distress among people with type 2 diabetes during a risk screening programme for diabetic kidney disease–longitudinal observations of the PRIORITY study LE Joensen, KP Madsen, M Frimodt-Møller, N Tofte, I Willaing, ... Journal of diabetes and its complications 34 (1), 107467, 2020 | 10 | 2020 |
| Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes I Khurana, H Kaipananickal, S Maxwell, S Birkelund, A Syreeni, ... The Journal of Clinical Investigation 133 (4), 2023 | 8 | 2023 |
| Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes HØ Hjortkjær, F Persson, S Theilade, SA Winther, N Tofte, TS Ahluwalia, ... Journal of Diabetes and its Complications 36 (9), 108270, 2022 | 7 | 2022 |
| Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes T Bjerre-Christensen, SA Winther, N Tofte, S Theilade, TS Ahluwalia, ... BMJ Open Diabetes Research and Care 9 (1), e002289, 2021 | 7 | 2021 |
